Bullfrog ai announces closing of $5.7 million public offering

Gaithersburg, md., feb. 05, 2024 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq:bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug development company using artificial intelligence (ai) and machine learning to enable the successful development of pharmaceuticals and biologics, announced today the closing of an underwritten public offering of an aggregate of 1,507,139 shares of common stock (or pre-funded warrants (“pre-funded warrants”) in lieu thereof) and accompanying warrants to purchase 1,507,139 shares of common stock at a public offering price of $3.782 per share (inclusive of the pre-funded warrant exercise price) for gross proceeds of approximately $5,700,000, prior to deducting underwriting discounts and offering expenses. in addition, the company has granted the underwriters a 45-day option to purchase an additional 226,071 shares of common stock (and/or pre-funded warrants in lieu thereof) and/or warrants to purchase 226,071 shares of common stock to cover over-allotments at the public offering price, less the underwriting discount.
BFRG Ratings Summary
BFRG Quant Ranking